Illumina, Inc. vs L3Harris Technologies Inc — how do they compare? Illumina, Inc. trades at $184.68 (market cap $27.94B), while L3Harris Technologies Inc trades at $277.71 (market cap $52.27B). The key difference: L3Harris Technologies Inc is the larger of the two by market cap, and L3Harris Technologies Inc pays a 1.78% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | LHX | |
|---|---|---|
Market Cap | $27.94B | $52.27B |
Sector | Health | Industrials |
52-Week High | $194.33 | $378.48 |
52-Week Low | $91.00 | $263.09 |
Enterprise Value | $29.33B | $63.03B |
Dividend Yield | — | 1.78% |
Trailing returns across standard periods
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →L3Harris Technologies was created in 2019 from the merger of L3 Technologies and Harris, two defense contractors that provide products for the command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR) market. The firm also has smaller operations serving the civil government, particularly the Federal Aviation Administration's communication infrastructure, and produces various avionics for defense and commercial aviation.
Read more on LHX →